1. Ferrante T, Manzoni GC, Russo M, Camarda C, Taga A, Veronesi L, et al. Prevalence of tension-type headache in adult general population: the PACE study and review of the literature. Neurol Sci [Internet]. 2013 [cited 2022 Jan 25];34 Suppl 1(SUPPL. 1). Available from: https://pubmed.ncbi.nlm.nih.gov/23695063/
2. Manzoni GC, Stovner LJ. Epidemiology of headache. Handb Clin Neurol. 2010;97:3–22.
3. Kowalska M, Prendecki M, Kozubski W, Lianeri M, Dorszewska J. Molecular factors in migraine. Oncotarget [Internet]. 2016 [cited 2022 Feb 8];7(31):50708. Available from: /pmc/articles/PMC5226615/
4. Borkum JM. Migraine Triggers and Oxidative Stress: A Narrative Review and Synthesis. Headache [Internet]. 2016 Jan 1 [cited 2022 Feb 8];56(1):12–35. Available from: https://pubmed.ncbi.nlm.nih.gov/26639834/
5. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology [Internet]. 2007 [cited 2022 Feb 8];68(21):1851–61. Available from: https://pubmed.ncbi.nlm.nih.gov/17515549/
6. Dale PC, Thomas JC, Hazle CR. Physical therapist clinical reasoning and classification inconsistencies in headache disorders: a United States survey. J Man Manip Ther [Internet]. 2020 Jan 1 [cited 2022 Jan 25];28(1):28–40. Available from: https://pubmed.ncbi.nlm.nih.gov/31373539/
7. Crystal SC, Robbins MS. Epidemiology of tension-type headache. Curr Pain Headache Rep. 2010 Dec;14(6):449–54.
8. Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019 Aug;123(2):e273–83.
9. Sanders AE, Shaikh SR, Slade GD. Long-chain omega-3 fatty acids and headache in the U.S. population. Prostaglandins Leukot Essent Fatty Acids [Internet]. 2018 Aug 1 [cited 2022 Jan 25];135:47–53. Available from: https://pubmed.ncbi.nlm.nih.gov/30103932/
10. Ramsden CE, Faurot KR, Zamora D, Palsson OS, MacIntosh BA, Gaylord S, et al. Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial. Pain. 2015 Apr;156(4):587–96.
11. Gazerani P. Migraine and Diet. Nutrients [Internet]. 2020 Jun 1 [cited 2022 Jan 25];12(6):1–11. Available from: https://pubmed.ncbi.nlm.nih.gov/32503158/
12. Zaeem Z, Zhou L, Dilli E. Headaches: a Review of the Role of Dietary Factors. Curr Neurol Neurosci Rep [Internet]. 2016 Nov 1 [cited 2022 Feb 8];16(11). Available from: https://pubmed.ncbi.nlm.nih.gov/27714637/
13. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A. 2003 Feb;100(4):1751–6.
14. De Caterina R, Madonna R, Massaro M. Effects of omega-3 fatty acids on cytokines and adhesion molecules. Curr Atheroscler Rep. 2004 Nov;6(6):485–91.
15. Forman MS, Lal D, Zhang B, Dabir D V, Swanson E, Lee VM-Y, et al. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci. 2005 Apr;25(14):3539–50.
16. Razeghi Jahromi S, Ghorbani Z, Martelletti P, Lampl C, Togha M. Association of diet and headache. J Headache Pain. 2019 Nov;20(1):106.
17. Ramsden CE, Zamora D, Faurot KR, MacIntosh B, Horowitz M, Keyes GS, et al. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial. BMJ. 2021 Jun;374:n1448.
18. Fritsche KL. The science of fatty acids and inflammation. Adv Nutr [Internet]. 2015 [cited 2022 Jan 25];6(3):293S-301S. Available from: https://pubmed.ncbi.nlm.nih.gov/25979502/
19. Elm E von, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLoS Med. 2007;4(10):1623–7.
20. Gago-Veiga AB, Camiña Muñiz J, García-Azorín D, González-Quintanilla V, Ordás CM, Torres-Ferrus M, et al. Headache: What to ask, how to examine, and what scales to use. Recommendations of the Spanish Society of Neurology’s Headache Study Group. Neurologia. Spanish Society of Neurology; 2019.
21. Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders. 3rd ed. Vol. 38. Cephalalgia. SAGE Publications Ltd; 1–211 p.
22. Shephard RJ. Qualified fitness and exercise as professionals and exercise prescription: Evolution of the PAR-Q and Canadian Aerobic Fitness Test. J Phys Act Heal. 2015 Apr 1;12(4):454–61.
23. Kosinski M, Bayliss MS, Bjorner JB, Ware JE, Garber WH, Batenhorst A, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res [Internet]. 2003 Dec [cited 2021 Nov 22];12(8):963–74. Available from: https://pubmed.ncbi.nlm.nih.gov/14651415/
24. Goni Mateos L, Aray Miranda M, Martínez AH, Cuervo Zapatel M. Validation of a food groups frequency questionnaire based in an exchange system. Nutr Hosp [Internet]. 2016 [cited 2021 Apr 26];33(6):1391–9. Available from: http://dx.doi.org/10.20960/nh.800
25. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002 Oct;56(8):365–79.
26. Ghasemi A, Zahediasl S. Normality tests for statistical analysis: A guide for non-statisticians. Int J Endocrinol Metab. 2012;10(2):486–9.
27. Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive Statistics for Studies in Sports Medicine and Exercise Science. Med Sci Sports Exerc. 2009;41(1):3–12.
28. Harcombe Z. US dietary guidelines: is saturated fat a nutrient of concern? Br J Sports Med. 2019;53(22):1393–6.
29. García Pérez de Sevilla G, Sánchez-Pinto Pinto B. Effectiveness of Workplace Mediterranean Diet Interventions on Cardiometabolic Risk Factors: A Systematic Review: Workplace Health Saf. 2022;
30. Yamanaka G, Suzuki S, Morishita N, Takeshita M, Kanou K, Takamatsu T, et al. Role of neuroinflammation and blood-brain barrier permutability on migraine. Int J Mol Sci. 2021 Aug 2;22(16).
31. Domínguez-Vivero C, Leira Y, López-Ferreiro A, Saavedra M, Rodríguez-Osorio X, Sobrino T, et al. Pentraxin 3 (PTX3): A Molecular Marker of Endothelial Dysfunction in Chronic Migraine. J Clin Med [Internet]. 2020 Mar 1 [cited 2022 Feb 8];9(3). Available from: /pmc/articles/PMC7141491/
32. Durham P, Papapetropoulos S. Biomarkers associated with migraine and their potential role in migraine management. Headache. 2013 Sep;53(8):1262–77.
33. Avona A, Price TJ, Dussor G. Interleukin-6 induces spatially dependent whole-body hypersensitivity in rats: implications for extracephalic hypersensitivity in migraine. J Headache Pain. 2021 Dec 1;22(1).
34. Sadeghi O, Maghsoudi Z, Khorvash F, Ghiasvand R, Askari G. The relationship between different fatty acids intake and frequency of migraine attacks. Iran J Nurs Midwifery Res [Internet]. 2015 [cited 2022 Jan 25];20(3):334. Available from: /pmc/articles/PMC4462058/
35. Patterson WL, Georgel PT. Breaking the cycle: The role of omega-3 polyunsaturated fatty acids in inflammation-driven cancers1. Biochem Cell Biol. 2014 Jul 8;92(5):321–8.
36. Ochi E, Tsuchiya Y. Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function. Nutrients [Internet]. 2018 Apr 29 [cited 2019 May 17];10(5):552. Available from: http://www.mdpi.com/2072-6643/10/5/552
37. Ramsden CE, Faurot KR, Zamora D, Suchindran CM, Macintosh BA, Gaylord S, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain [Internet]. 2013 [cited 2022 Feb 8];154(11):2441–51. Available from: https://pubmed.ncbi.nlm.nih.gov/23886520/
38. Boyd JT, LoCoco PM, Furr AR, Bendele MR, Tram M, Li Q, et al. Elevated dietary ω-6 polyunsaturated fatty acids induce reversible peripheral nerve dysfunction that exacerbates comorbid pain conditions. Nat Metab [Internet]. 2021 Jun 1 [cited 2022 Feb 8];3(6):762–73. Available from: https://pubmed.ncbi.nlm.nih.gov/34140694/
39. Claudia Torrejón D. Mercurio y Salud. Rev Med Chile. 2014;142:1174–80.